EDAP TMS SA (NASDAQ:EDAP) ("the Company"), the global leader in robotic therapeutic ultrasound, today announced that the Company has received approval from French authorities to initiate a Phase 3 randomized,
Edap TMS (NASDAQ:EDAP) is set to give its latest quarterly earnings report on Wednesday, 2022-11-16. Here's what investors need to know before the announcement.
Analysts estimate that Edap TMS will report an earnings per share (EPS) of $-0.06.
EDAP TMS SA (NASDAQ:EDAP) ("the Company"), the global leader in robotic therapeutic ultrasound, today announced that the U.S. Centers for Medicare and Medicaid Services (CMS) has released its final outpatient
U.S. stock futures traded lower this morning after recording losses in the previous session. Here are some big stocks moving lower in today’s pre-market trading session.
EDAP TMS S.A. (NASDAQ: EDAP) announced that the price of its public offering of its American Depositary Shares ("ADSs"), which commenced on September 22, 2022, has been set today at $7.50 per ADS, before underwriting discounts and commissions, and that the number of offered ADSs is 2,666,667.